.png)
Clinical Trials Market By Phase, Study Design and Indication - Global Industry Analysis & Forecast to 2027
Published On : February 2019 Pages : 160 Category: Pharma & Healthcare Report Code : HC022711
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Clinical Trials Market By Phase (Phase I, Phase II, Phase III, Phase IV) Study Design (Observational, Interventional, Expanded Access) Indication (Pain management, CNS condition, Obesity, Autoimmune, Oncology, Diabetes, Cardiovascular, Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Clinical Trials Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Clinical trials are fundamental for the improvement of new medications. Regardless of whether an individual ought to partake relies upon their comprehension of the dangers and advantages for themselves and for society overall. Creating economies, for example, India clinical trials market is anticipated to demonstrate alluring markets inferable from expanding accessibility of master professionals, developing government support concerning improvement of the outsourcing hubs.
Drivers and Restraints
Virtual improvement models are anticipated to give new pathways to the clinical trials market sooner rather than later with flooding request from the pharmaceutical organizations. Advent of new meds, for example, customized medication and developing interest for CROs for directing clinical preliminaries is anticipated to drive clinical trials market over the globe. Developing number of patients experiencing uncommon sicknesses offers biopharmaceutical organizations fabricating openings, which thusly drives them to make substantial interests in clinical trials.
Regional Insights
North America drove the general market on the basis of revenue share in 2018, inferable from the existencing of huge outsourcing firms and expanding R&D in the district.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Laboratory Corporation of America
- ICON plc
- PAREXEL International Corporation
- Pharmaceutical Product Development LLC
- F. Hoffmann-La Roche Ltd
- Wuxi AppTec
- Clinipace
- Eli Lilly and Company
- Novo Nordisk A/S
- Pfizer Inc.
- IQVIA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Clinical Trials Market, By Phase, Estimates and Forecast, 2017-2027($Billion)
o Phase I
o Phase II
o Phase III
o Phase IV
· Clinical Trials Market, By Study Design, Estimates and Forecast, 2017-2027($Billion)
o Observational
o Interventional
o Expanded Access
· Clinical Trials Market, By Indication, Estimates and Forecast, 2017-2027($Billion)
o Pain management
o CNS condition
o Obesity
o Autoimmune
o Oncology
o Diabetes
o Cardiovascular
o Others
· Clinical Trials Market, By Region, Estimates and Forecast, 2017-2027($Billion)
o North America
§ North America Clinical Trials Market, By Country
o U.S. Clinical Trials Market
o Canada Clinical Trials Market
o Mexico Clinical Trials Market
o Europe
§ Europe Clinical Trials Market, By Country
o Germany Clinical Trials Market
o UK Clinical Trials Market
o France Clinical Trials Market
o Russia Clinical Trials Market
o Italy Clinical Trials Market
o Rest of Europe Clinical Trials Market
o Asia-Pacific
§ Asia-Pacific Clinical Trials Market, By Country
o China Clinical Trials Market
o Japan Clinical Trials Market
o South Korea Clinical Trials Market
o India Clinical Trials Market
o Southeast Asia Clinical Trials Market
o Rest of Asia-Pacific Clinical Trials Market
o South America
§ South America Clinical Trials Market
o Brazil Clinical Trials Market
o Argentina Clinical Trials Market
o Columbia Clinical Trials Market
o Rest of South America Clinical Trials Market
o Middle East and Africa
§ Middle East and Africa Clinical Trials Market
o Saudi Arabia Clinical Trials Market
o UAE Clinical Trials Market
o Egypt Clinical Trials Market
o Nigeria Clinical Trials Market
o South Africa Clinical Trials Market
o Rest of MEA Clinical Trials Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Clinical Trials Market, By Phase
5.1. Introduction
5.2. Global Clinical Trials Revenue and Market Share by Phase (2017-2027)
5.2.1. Global Clinical Trials Revenue and Revenue Share by Phase (2017-2027)
5.3. Phase I
5.3.1. Global Phase I Revenue and Growth Rate (2017-2027)
5.4. Phase II
5.4.1. Global Phase II Revenue and Growth Rate (2017-2027)
5.5. Phase III
5.5.1. Global Phase III Revenue and Growth Rate (2017-2027)
5.6. Phase IV
5.6.1. Global Phase IV Revenue and Growth Rate (2017-2027)
6. Clinical Trials Market, By Study Design
6.1. Introduction
6.2. Global Clinical Trials Revenue and Market Share by Study Design (2017-2027)
6.2.1. Global Clinical Trials Revenue and Revenue Share by Study Design (2017-2027)
6.3. Observational
6.3.1. Global Observational Revenue and Growth Rate (2017-2027)
6.4. Interventional
6.4.1. Global Interventional Revenue and Growth Rate (2017-2027)
6.5. Expanded Access
6.5.1. Global Expanded Access Revenue and Growth Rate (2017-2027)
7. Clinical Trials Market, By Indication
7.1. Introduction
7.2. Global Clinical Trials Revenue and Market Share by Indication (2017-2027)
7.2.1. Global Clinical Trials Revenue and Revenue Share by Indication (2017-2027)
7.3. Pain management
7.3.1. Global Pain management Revenue and Growth Rate (2017-2027)
7.4. CNS condition
7.4.1. Global CNS condition Revenue and Growth Rate (2017-2027)
7.5. Obesity
7.5.1. Global Obesity Revenue and Growth Rate (2017-2027)
7.6. Autoimmune
7.6.1. Global Autoimmune Revenue and Growth Rate (2017-2027)
7.7. Oncology
7.7.1. Global Oncology Revenue and Growth Rate (2017-2027)
7.8. Diabetes
7.8.1. Global Diabetes Revenue and Growth Rate (2017-2027)
7.9. Cardiovascular
7.9.1. Global Cardiovascular Revenue and Growth Rate (2017-2027)
7.10. Others
7.10.1. Global Others Revenue and Growth Rate (2017-2027)
8. Clinical Trials Market, By Region
8.1. Introduction
8.2. Global Clinical Trials Revenue and Market Share by Regions
8.2.1. Global Clinical Trials Revenue by Regions (2017-2027)
8.3. North America Clinical Trials by Countries
8.3.1. North America Clinical Trials Revenue and Growth Rate (2017-2027)
8.3.2. North America Clinical Trials Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Clinical Trials by Countries
8.4.1. Europe Clinical Trials Revenue and Growth Rate (2017-2027)
8.4.2. Europe Clinical Trials Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Clinical Trials by Countries
8.5.1. Asia-Pacific Clinical Trials Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Clinical Trials Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Clinical Trials by Countries
8.6.1. South America Clinical Trials Revenue and Growth Rate (2017-2027)
8.6.2. South America Clinical Trials Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Clinical Trials by Countries
8.7.1. Middle East and Africa Clinical Trials Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Clinical Trials Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Laboratory Corporation of America
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. ICON plc
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. PAREXEL International Corporation
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. Pharmaceutical Product Development LLC
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. F. Hoffmann-La Roche Ltd
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. Wuxi AppTec
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. Clinipace
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. Eli Lilly and Company
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. Novo Nordisk A/S
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
9.10. Pfizer Inc.
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Financial Overview
9.11. IQVIA
9.11.1. Business Overview
9.11.2. Service Portfolio
9.11.3. Strategic Developments
9.11.4. Financial Overview
10. Global Clinical Trials Market Competition, by Manufacturer
10.1. Global Clinical Trials Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global Clinical Trials Price By Region (2017-2017)
10.3. Top 5 Clinical Trials Manufacturer Market Share
10.4. Market Competition Trend
11. Clinical Trials Market Forecast (2017-2027)
11.1. Global Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Clinical Trials Market Forecast by Regions (2017-2027)
11.2.1. North America Clinical Trials Market Forecast (2017-2027)
11.2.1.1. United States Clinical Trials Market Forecast (2017-2027)
11.2.1.2. Canada Clinical Trials Market Forecast (2017-2027)
11.2.1.3. Mexico Clinical Trials Market Forecast (2017-2027)
11.2.2. Europe Clinical Trials Market Forecast (2017-2027)
11.2.2.1. Germany Clinical Trials Market Forecast (2017-2027)
11.2.2.2. France Clinical Trials Market Forecast (2017-2027)
11.2.2.3. UK Clinical Trials Market Forecast (2017-2027)
11.2.2.4. Russia Clinical Trials Market Forecast (2017-2027)
11.2.2.5. Italy Clinical Trials Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Clinical Trials Market Forecast (2017-2027)
11.2.3. Asia-Pacific Clinical Trials Market Forecast (2017-2027)
11.2.3.1. China Clinical Trials Market Forecast (2017-2027)
11.2.3.2. Japan Clinical Trials Market Forecast (2017-2027)
11.2.3.3. Korea Clinical Trials Market Forecast (2017-2027)
11.2.3.4. India Clinical Trials Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Clinical Trials Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Clinical Trials Market Forecast (2017-2027)
11.2.4. South America Clinical Trials Market Forecast (2017-2027)
11.2.4.1. Brazil Clinical Trials Market Forecast (2017-2027)
11.2.4.2. Argentina Clinical Trials Market Forecast (2017-2027)
11.2.4.3. Columbia Clinical Trials Market Forecast (2017-2027)
11.2.4.4. Rest of South America Clinical Trials Market Forecast (2017-2027)
11.2.5. Middle East and Africa Clinical Trials Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Clinical Trials Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Clinical Trials Market Forecast (2017-2027)
11.2.5.3. Egypt Clinical Trials Market Forecast (2017-2027)
11.2.5.4. Nigeria Clinical Trials Market Forecast (2017-2027)
11.2.5.5. South Africa Clinical Trials Market Forecast (2017-2027)
11.2.5.6. Turkey Clinical Trials Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Clinical Trials Market Forecast (2017-2027)
11.3. Clinical Trials Market Forecast by Phase (2017-2027)
11.3.1. Clinical Trials Forecast by Phase (2017-2027)
11.3.2. Clinical Trials Market Share Forecast by Phase (2017-2027)
11.4. Clinical Trials Market Forecast by Study Design (2017-2027)
11.4.1. Clinical Trials Forecast by Study Design (2017-2027)
11.4.2. Clinical Trials Market Share Forecast by Study Design (2017-2027)
11.5. Clinical Trials Market Forecast by Indication (2017-2027)
11.5.1. Clinical Trials Forecast by Indication (2017-2027)
11.5.2. Clinical Trials Market Share Forecast by Indication (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Clinical Trials Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Clinical Trials Revenue and Revenue Share by Phase (2017-2018)
Figure Global Phase I Revenue and Growth Rate (2017-2018)
Figure Global Phase II Revenue and Growth Rate (2017-2018)
Figure Global Phase III Revenue and Growth Rate (2017-2018)
Figure Global Phase IV Revenue and Growth Rate (2017-2018)
Table Global Clinical Trials Revenue and Revenue Share by Study Design (2017-2018)
Figure Global Observational Revenue and Growth Rate (2017-2018)
Figure Global Interventional Revenue and Growth Rate (2017-2018)
Figure Global Expanded Access Revenue and Growth Rate (2017-2018)
Table Global Clinical Trials Revenue and Revenue Share by Indication (2017-2018)
Figure Global Pain management Revenue and Growth Rate (2017-2018)
Figure Global CNS condition Revenue and Growth Rate (2017-2018)
Figure Global Obesity Revenue and Growth Rate (2017-2018)
Figure Global Autoimmune Revenue and Growth Rate (2017-2018)
Figure Global Oncology Revenue and Growth Rate (2017-2018)
Figure Global Diabetes Revenue and Growth Rate (2017-2018)
Figure Global Cardiovascular Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Clinical Trials Revenue by Regions (2017-2018)
Figure North America Clinical Trials Growth Rate (2017-2018)
Figure North America Clinical Trials Revenue and Growth Rate (2017-2018)
Figure North America Clinical Trials by Countries (2017-2018)
Figure North America Clinical Trials Revenue (Million USD) by Countries (2017-2018)
Figure United States Clinical Trials Growth Rate (2017-2018)
Figure United States Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Clinical Trials Growth Rate (2017-2018)
Figure Canada Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Clinical Trials Growth Rate (2017-2018)
Figure Mexico Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Clinical Trials Growth Rate (2017-2018)
Figure Europe Clinical Trials Revenue and Growth Rate (2017-2018)
Figure Europe Clinical Trials by Countries (2017-2018)
Figure Europe Clinical Trials Revenue (Million USD) by Countries (2017-2018)
Figure Germany Clinical Trials Growth Rate (2017-2018)
Figure Germany Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Clinical Trials Growth Rate (2017-2018)
Figure France Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Clinical Trials Growth Rate (2017-2018)
Figure UK Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Clinical Trials Growth Rate (2017-2018)
Figure Russia Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Clinical Trials Growth Rate (2017-2018)
Figure Italy Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Clinical Trials Growth Rate (2017-2018)
Figure Rest of Europe Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Clinical Trials Growth Rate (2017-2018)
Figure Asia-Pacific Clinical Trials Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Clinical Trials by Countries (2017-2018)
Figure Asia-Pacific Clinical Trials Revenue (Million USD) by Countries (2017-2018)
Figure China Clinical Trials Growth Rate (2017-2018)
Figure China Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Clinical Trials Growth Rate (2017-2018)
Figure Japan Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Clinical Trials Growth Rate (2017-2018)
Figure Korea Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Clinical Trials Growth Rate (2017-2018)
Figure India Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Clinical Trials Growth Rate (2017-2018)
Figure Southeast Asia Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Clinical Trials Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Clinical Trials Growth Rate (2017-2018)
Figure South America Clinical Trials Revenue and Growth Rate (2017-2018)
Figure South America Clinical Trials by Countries (2017-2018)
Figure South America Clinical Trials Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Clinical Trials Growth Rate (2017-2018)
Figure Brazil Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Clinical Trials Growth Rate (2017-2018)
Figure Argentina Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Clinical Trials Growth Rate (2017-2018)
Figure Columbia Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Clinical Trials Growth Rate (2017-2018)
Figure Rest of South America Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Clinical Trials Growth Rate (2017-2018)
Figure Middle East and Africa Clinical Trials Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Clinical Trials by Countries (2017-2018)
Figure Middle East and Africa Clinical Trials Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Clinical Trials Growth Rate (2017-2018)
Figure Saudi Arabia Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Clinical Trials Growth Rate (2017-2018)
Figure United Arab Emirates Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Clinical Trials Growth Rate (2017-2018)
Figure Egypt Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Clinical Trials Growth Rate (2017-2018)
Figure Nigeria Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Clinical Trials Growth Rate (2017-2018)
Figure South Africa Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Clinical Trials Growth Rate (2017-2018)
Figure Turkey Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Clinical Trials Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Clinical Trials Revenue (Millions USD) and Growth Rate (2017-2018)
Table Laboratory Corporation of America Clinical Trials Price, Revenue, Gross Margin and Market Share (2017-2017)
Table ICON plc Clinical Trials Price, Revenue, Gross Margin and Market Share (2017-2017)
Table PAREXEL International Corporation Clinical Trials Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pharmaceutical Product Development LLC Clinical Trials Price, Revenue, Gross Margin and Market Share (2017-2017)
Table F. Hoffmann-La Roche Ltd Clinical Trials Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Wuxi AppTec Clinical Trials Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Clinipace Clinical Trials Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Eli Lilly and Company Clinical Trials Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novo Nordisk A/S Clinical Trials Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Inc. Clinical Trials Price, Revenue, Gross Margin and Market Share (2017-2017)
Table IQVIA Clinical Trials Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Clinical Trials Market Share by Manufacturer
Figure Global Clinical Trials Revenue and Market Share by Manufacturer
Table Global Clinical Trials Price by Region (2017-2017)
Figure Top 5 Clinical Trials Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Clinical Trials Revenue (Millions USD) and Growth Rate (2018-2025)
Table Clinical Trials Market Forecast by Regions (2018-2025)
Figure North America Clinical Trials Market Forecast (2018-2025)
Figure United States Clinical Trials Market Forecast (2018-2025)
Figure Canada Clinical Trials Market Forecast (2018-2025)
Figure Mexico Clinical Trials Market Forecast (2018-2025)
Figure Europe Clinical Trials Market Forecast (2018-2025)
Figure Germany Clinical Trials Market Forecast (2018-2025)
Figure France Clinical Trials Market Forecast (2018-2025)
Figure UK Clinical Trials Market Forecast (2018-2025)
Figure Russia Clinical Trials Market Forecast (2018-2025)
Figure Italy Clinical Trials Market Forecast (2018-2025)
Figure Rest of Europe Clinical Trials Market Forecast (2018-2025)
Figure Asia-Pacific Clinical Trials Market Forecast (2018-2025)
Figure China Clinical Trials Market Forecast (2018-2025)
Figure Japan Clinical Trials Market Forecast (2018-2025)
Figure Korea Clinical Trials Market Forecast (2018-2025)
Figure India Clinical Trials Market Forecast (2018-2025)
Figure Southeast Asia Clinical Trials Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Clinical Trials Market Forecast (2018-2025)
Figure South America Clinical Trials Market Forecast (2018-2025)
Figure Brazil Clinical Trials Market Forecast (2018-2025)
Figure Argentina Clinical Trials Market Forecast (2018-2025)
Figure Columbia Clinical Trials Market Forecast (2018-2025)
Figure Rest of South America Clinical Trials Market Forecast (2018-2025)
Figure Middle East and Africa Clinical Trials Market Forecast (2018-2025)
Figure Saudi Arabia Clinical Trials Market Forecast (2018-2025)
Figure United Arab Emirates Clinical Trials Market Forecast (2018-2025)
Figure Egypt Clinical Trials Market Forecast (2018-2025)
Figure Nigeria Clinical Trials Market Forecast (2018-2025)
Figure South Africa Clinical Trials Market Forecast (2018-2025)
Figure Turkey Clinical Trials Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Clinical Trials Market Forecast (2018-2025)
Figure Global Clinical Trials Forecast by Phase (2018-2025)
Figure Global Clinical Trials Market Share Forecast by Phase (2018-2025)
Figure Global Clinical Trials Forecast by Phase (2018-2025)
Figure Global Clinical Trials Forecast by Study Design (2018-2025)
Figure Global Clinical Trials Market Share Forecast by Study Design (2018-2025)
Figure Global Clinical Trials Forecast by Study Design (2018-2025)
Figure Global Clinical Trials Forecast by Indication (2018-2025)
Figure Global Clinical Trials Market Share Forecast by Indication (2018-2025)
Figure Global Clinical Trials Forecast by Indication (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|